1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Page states applications are accepted year-round; submit at least six weeks before the activity start date.
Corporate Giving in Latin America & the Caribbean is sponsored by Gilead Sciences. Gilead Sciences provides grants for innovative projects in Latin America and the Caribbean focusing on HIV and liver diseases (HCV, HBV, HDV).
Funding priorities include increasing awareness and understanding of HIV incidence and treatment methods, facilitating medicine provision and local provider expertise, supporting linkage to care programs, identifying and fostering prevention programs for at-risk individuals (including PrEP), and improving diagnostics and building medical specialization for hepatitis B and C.
Projects should aim to improve access to healthcare, reduce disparities, and advance education among patients and healthcare professionals. Universities are eligible as they often partner with local organizations for research and public health initiatives.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Gilead Sciences: Corporate Giving in Latin America & the Caribbean Giving in Latin America & the Caribbean Giving in Latin America the Caribbean We work with patient advocates, nonprofits and healthcare professionals across all our therapeutic areas of focus to improve care through partnerships and community engagement.
Latin America & the Caribbean For years, Gilead has worked with local partners to provide our medicines throughout Latin America and the Caribbean. Our efforts focus on addressing unmet medical needs in the region, bringing innovative treatments to communities in Argentina, Belize, Brazil, Haiti, Jamaica and beyond.
Following our mission to create a healthier world for all people, we identify and support organizations that seek to: Improve access to healthcare Reduce disparities for disadvantaged groups Advance education among patients and healthcare professionals Support local communities In Latin America and the Caribbean, funding priority is given to projects that address HIV and liver diseases. St.
Vincent & The Grenadines We’re committed to ending the HIV epidemic in Latin America and the Caribbean. Numerous factors are driving the epidemic in this region. The social stigma of HIV-positive status leads many to decline treatment or travel great distances to be treated outside their community.
Elsewhere, poor treatment options for incarcerated populations (a group that faces systemic barriers to receiving quality HIV care) leads to public health concerns as individuals complete their rehabilitation programs and re-enter society. We support organizations working to help individuals learn their HIV status and get the care they need.
We also fund local groups looking to meet the unique needs of the region, including: Increasing awareness and understanding of HIV incidence and treatment methods Facilitating medicine provision and local provider expertise Supporting linkage to care programs Identifying and fostering prevention programs for at-risk individuals, including via pre-exposure prophylaxis (PrEP) In Latin America and the Caribbean, many people are living with undiagnosed hepatitis C, driven in part by a lack of disease awareness and diagnosis options have contributed to the persistence of this gap.
Our grantee partners seek to increase awareness of risk factors and the educational tools available to patient communities throughout the region. We also fund projects to improve diagnostics and build medical specialization in hepatitis B (HBV) and HCV.
We are working to improve the overall continuum of care for liver diseases by funding organizations that: Ensure providers have the training and expertise they need to deliver proper care Improve infrastructure and screening ability of regions where care is dependent on viral load Reduce undiagnosed totals Increase awareness of risk factors 1.
Review Our Guidelines to Ensure Your Project Is Eligible Before applying, carefully review Apply for Funding , Terms and Conditions and FAQs . If you are looking for other types of funding, see also Medical Education and Research Funding Programs . 2.
Ensure You Have a Valid Nonprofit Legal Registration You are required to be a nonprofit organization in order to be considered for funding. Proof of your status is required prior to submitting an application. You will submit your grant application via our secure online system .
4.
Complete the Online Application Be prepared to submit the following information to the online application: Dates and locations of project events (please note that grant funding is not provided for more than one year at a time and is not provided for events or programs that have already occurred) Final event agenda (please do not include the names or affiliations of presenting speakers) Target audience and publicity plan Detailed project budget, including a breakdown of how you will use the funds requested from Gilead, as well as total estimated project expenses Note: The portal offers the option to save an uncompleted draft and return to it at another time.
5. Review and Finalize Your Application Please review your application carefully before submitting it, as changes cannot be made after submission. We will send you a confirmation email after receiving your application.
We accept grant applications year-round. Keep in mind that you must submit the application at least six weeks before your activity begins, and that it typically takes approximately six to 12 weeks for review. We will email the contact listed on your grant account profile with notification of the funding decision.
Access How to Apply for Funding With All Countries
According to the current listing, eligibility includes: Organizations that seek to improve access to healthcare, reduce disparities for disadvantaged groups, advance education among patients and healthcare professionals, and support local communities in Latin America and the Caribbean, with a focus on HIV and liver diseases. This includes universities partnering with local entities. Confirm the full requirements in the official notice before applying.
Corporate Giving in Latin America & the Caribbean is funded by Gilead Sciences. Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
The U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleSchmidt Sciences opened a 'Scaling AI Safety for a Multi-Agent World' program with awards up to $1 million and an August 8, 2026 deadline. Against a backdrop of federal research slowdowns, here is why private science philanthropy matters more than ever, how these funders differ from federal agencies, and how researchers should approach them.
Read articleNSF's Arctic Research Opportunities solicitation funds roughly 75 awards a year — up to $50 million — across six program areas from natural sciences to social sciences to the Arctic Observing Network. The July 15, 2026 target date is not a hard deadline, and understanding that distinction is the first strategic decision an Arctic researcher makes. Here is how the six doors differ and how to choose the right one.
Read article